Hypolipidemic Agents: Clinical Trials

3 trials of Hypolipidemic Agents, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 2, Recruiting 1

Follow Hypolipidemic Agents: new trials by email Literature Review of Hypolipidemic Agents trials Research Report on Hypolipidemic Agents

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Anti-inflammatory Therapy for Recurrent In-stent Restenosis
Colchicine, Prednisone, Aspirin - In-stent Restenosis
Phase 4RecruitingFu Wai Hospital, Beijing, China2522023-10-302025-08-08
Role of Fenofibrate in Neonatal Jaundice
Fenofibrate, placebo - Neonatal Jaundice
Phase 4CompletedAin Shams University752023-07-012024-06-11
Effect of Pioglitazone on Insulin Resistance, Atherosclerosis Progression and Clinical Course of Coronary Heart Disease
Pioglitazone 15 mg Tablet, Isosorbide Dinitrate 10Mg Tablet, Acetylsalicylic Acid 75Mg Tablet - Adverse Effect, Atherosclerosis, Coronary
Phase 4CompletedUkrainian Medical Stomatological Academy432012-11-012022-03-10

Conditions studied

Atherosclerosis (1)  ·  Coronary Artery Disease (1)  ·  Coronary Disease (1)  ·  Insulin Resistance (1)  ·  Jaundice, Neonatal (1)  ·  Metabolic Syndrome (1)

Sponsors

Ain Shams University (1)  ·  Fu Wai Hospital, Beijing, China (1)  ·  Ukrainian Medical Stomatological Academy (1)

Countries

China (1)  ·  Egypt (1)  ·  Ukraine (1)

Top investigators

Haiyan Qian (1)

Results publications

PMID 41145262